Faculty profile

Daphne Voineskos

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Daphne Voineskos

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
30 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2026.
Supervised 1 trainee who won CIHR awards, most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

426

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Chronic Pain Depression Platform Trial Bipolar Depression Efficacy Randomized Controled Trial Repetitive Transcranial Magnetic Stimulation Safety

Latest papers

Peripheral GABAergic markers in late-life depression: Links to clinical outcomes.
Brain research · 2026
Symptom trajectories and treatment outcomes following a five-day accelerated intermittent-theta burst stimulation protocol for treatment-resistant depression: A naturalistic study in a real-world setting.
Psychiatry research · 2026
Effects of theta burst stimulation on neural connectivity and visual perception following attention modification of own-face viewing in body dysmorphic disorder.
medRxiv : the preprint server for health sciences · 2026

All 55 publications

Latest funding

Creatine Monohydrate Relative to Placebo for Treatment of Mood Disorders
CIHR · 2026 · Co-investigator
$742,050
The PLATform for INnovative Multicentre trials for comorbid chronic Pain and Depressive disorders (PLATINuM-PD)
CIHR · 2026 · Principal investigator
$730,576
Investigating the Neurophysiological Mechanisms of Therapeutic Psilocybin in Patients with Treatment Resistant Depression.
CIHR · 2025 · Supervisor
$120,000

All 8 grants and awards

55 publications.

Peripheral GABAergic markers in late-life depression: Links to clinical outcomes.

Rezaei S, Sibille E, Voineskos D, Rajji TK, Nikolova YS, Diniz BS, Vieira EL

Brain research2026

DOI: 10.1016/j.brainres.2026.150365 PMID: 42086139

Symptom trajectories and treatment outcomes following a five-day accelerated intermittent-theta burst stimulation protocol for treatment-resistant depression: A naturalistic study in a real-world setting.

Janssen-Aguilar R, Joseph J, Al-Shamali HF, Menzies P, Dunlop K, Jha M, Lin Q, Lou W, Adamsahib F, Mulsant BH, Tang VM, Voineskos D, Blumberger DM, Kaster TS, Bhat V

Psychiatry research2026

DOI: 10.1016/j.psychres.2026.117264 PMID: 42263622

Effects of theta burst stimulation on neural connectivity and visual perception following attention modification of own-face viewing in body dysmorphic disorder.

Diaz-Fong JP, Peel HJ, Zhang K, Qian J, Lewis M, Wong WW, Leuchter AF, Tadayonnejad R, Voineskos D, Konstantinou G, Lam E, Blumberger DM, Feusner JD

medRxiv : the preprint server for health sciences2026

DOI: 10.64898/2026.05.25.26354053 PMID: 42245010

Confirmatory efficacy and safety trial of magnetic seizure therapy versus right unilateral ultra-brief electroconvulsive therapy in depression (CREST-MST): a randomised, double-blind, non-inferiority trial in Canada and the USA.

Blumberger DM, McClintock SM, Thorpe KE, Tamminga CA, Foley K, Husain MM, Kaster TS, Knyahnytska Y, Voineskos D, Bailey KJ, Hubregsen JJ, Weissman CR, Daskalakis ZJ

The lancet. Psychiatry2026

DOI: 10.1016/s2215-0366(26)00060-x PMID: 41997695

Neurophysiological signatures of Stanford Neuromodulation Therapy in treatment resistant depression.

Momi D, Buchanan DM, Wada M, Geoly AD, Johnson NJ, Cole EJ, Maron-Katz A, Tischler C, Cline CC, Pizzagalli DA, Saggar M, Voineskos D, Griffiths JD, Rolle CE, Keller CJ, Williams N

Molecular psychiatry2026

DOI: 10.1038/s41380-026-03837-4 PMID: 42686996

Symptom trajectories and clinical outcomes of intravenous ketamine in treatment-resistant depression: A real-world study using group-based trajectory modeling.

Janssen-Aguilar R, Joseph J, Al-Shamali H, Menzies P, Dunlop K, Jha M, Lin Q, Lou W, Adamsahib F, Mulsant B, Tang VM, Voineskos D, Blumberger DM, Kaster TS, Bhat V

Journal of affective disorders2026

DOI: 10.1016/j.jad.2026.121230 PMID: 41581838

Clinical utility and prospective of TMS-EEG: Updated review from an international expert group.

Ziemann U, Bai Y, Baumer FM, Beck MM, Belardinelli P, Belvisi D, Bender S, Bergmann TO, Bortoletto M, Casarotto S, Casula E, Chaves AR, de Andrade DC, Conte A, Daskalakis ZJ, Farzan F, Ferrarelli F, Fitzgerald PB, Gordon PC, Grefkes C, Harquel S, Hernandez-Pavon JC, Hill AT, Hoy KE, Hummel FC, Julkunen P, Kallioniemi E, Keller CJ, Kimiskidis VK, Kirkovski M, Koch G, Leodori G, Lioumis P, Määttä S, Maidan I, Massimini M, Mengel A, Metsomaa J, Miniussi C, Mutanen TP, Noda Y, Ozdemir RA, Raffin E, Rocchi L, Rogasch NC, Rosanova M, Santarnecchi E, Sarasso S, Schabrun SM, Shafi MM, Siebner HR, Tolner EA, Tomasevic L, Tremblay S, Tscherpel C, Veniero D, Versace V, Voineskos D, Vucic S, Zangen A, Zrenner C, Ilmoniemi RJ

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology2026

DOI: 10.1016/j.clinph.2025.2111487 PMID: 41688232

Fluorodeoxyglucose-Positron Emission Tomography as a Preoperative Biomarker for Predicting and Optimizing Response to Subcallosal Cingulate Area Deep Brain Stimulation.

Elias GJB, Iskin SA, Beyn ME, Omere U, Rizvi SJ, Ceniti AK, Boutet A, Voineskos D, Kennedy SH, Lozano AM, Germann J

Biological psychiatry2026

DOI: 10.1016/j.biopsych.2025.05.009 PMID: 40403825

Extended course accelerated intermittent theta burst stimulation as a substitute for depressed patients needing electroconvulsive therapy.

Goodman MS, Trevizol AP, Konstantinou GN, Boivin-Lafleur D, Brender R, Downar J, Kaster TS, Knyahnytska Y, Vila-Rodriguez F, Voineskos D, Daskalakis ZJ, Blumberger DM

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025

DOI: 10.1038/s41386-024-02007-w PMID: 39443721

The neural correlates of illness awareness in addiction: a pilot exploratory analysis of preliminary data from the cognitive dysfunction in the addictions (CDiA) research program.

Kyte S, Song J, Nikolova YS, Ruocco AC, Agarwal SM, Amaev A, Bukovsky D, Carmona-Torres E, Felsky D, Graff-Guerrero A, Lange S, Prevot TD, Quilty LC, Remington G, Sibille E, Strafella AP, Ueno F, Vieira E, Voineskos D, Gerretsen P

Frontiers in neurology2025

DOI: 10.3389/fneur.2025.1694826 PMID: 41561341

Something wrong or missing on this profile? Suggest a correction

Daphne Voineskos

Research

Latest papers

Latest funding

Peripheral GABAergic markers in late-life depression: Links to clinical outcomes.

Symptom trajectories and treatment outcomes following a five-day accelerated intermittent-theta burst stimulation protocol for treatment-resistant depression: A naturalistic study in a real-world setting.

Effects of theta burst stimulation on neural connectivity and visual perception following attention modification of own-face viewing in body dysmorphic disorder.

Confirmatory efficacy and safety trial of magnetic seizure therapy versus right unilateral ultra-brief electroconvulsive therapy in depression (CREST-MST): a randomised, double-blind, non-inferiority trial in Canada and the USA.

Neurophysiological signatures of Stanford Neuromodulation Therapy in treatment resistant depression.

Symptom trajectories and clinical outcomes of intravenous ketamine in treatment-resistant depression: A real-world study using group-based trajectory modeling.

Clinical utility and prospective of TMS-EEG: Updated review from an international expert group.

Fluorodeoxyglucose-Positron Emission Tomography as a Preoperative Biomarker for Predicting and Optimizing Response to Subcallosal Cingulate Area Deep Brain Stimulation.

Extended course accelerated intermittent theta burst stimulation as a substitute for depressed patients needing electroconvulsive therapy.

The neural correlates of illness awareness in addiction: a pilot exploratory analysis of preliminary data from the cognitive dysfunction in the addictions (CDiA) research program.

Frequent collaborators

Jonathan Downar

Bernard Le Foll

Robert Chen

Fidel Vila-Rodriguez

Etienne Sibille

Erica Vieira

Christoph Zrenner

Philip Gerretsen

Faranak Farzan

Wei Wang

Shannon Lange

Daniel Felsky

Colin Hawco

Venkat Bhat

Kevin Shield

Victor Tang

Samantha Wells

Katharine Dunlop

Tyler Kaster

Wendy Lou

Osnat Melamed

Gerasimos Konstantinou

George Foussias

Daniel Blumberger

Samantha Wells

Ayal Schaffer

Brigitte Zrenner

Serge Beaulieu

Gayatri Saraf

Marco Solmi

Peter Giacobbe

Alexander Mcgirr

Nikki Bozinoff

Benicio Frey

Benoit Mulsant

John Strauss

Isabelle Boileau

Paul Kurdyak

Zahinoor Ismail

Wei Zhang